Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Illumina HiSeq 3000 (Homo sapiens)
SNU-449 ALK targeted inhibition cells (Replicate_3)
SRA Run Selector
SNU-449 ALK targeted inhibition cells (Replicate_2)
SNU-449 ALK targeted inhibition cells (Replicate_1)
SNU-449 Non-Target Expressing cells (Replicate_3)
SNU-449 Non-Target Expressing cells (Replicate_2)
SNU-449 Non-Target Expressing cells (Replicate_1)
SK-HEP1 ALK targeted inhibition cells (Replicate_3)
SK-HEP1 ALK targeted inhibition cells (Replicate_2)
SK-HEP1 ALK targeted inhibition cells (Replicate_1)
SK-HEP1 Non-Target Expressing cells (Replicate_3)
SK-HEP1 Non-Target Expressing cells (Replicate_2)
SK-HEP1 Non-Target Expressing cells (Replicate_1)
HepG2/C3A ALK targeted inhibition cells (Replicate_3)
HepG2/C3A ALK targeted inhibition cells (Replicate_2)
HepG2/C3A ALK targeted inhibition cells (Replicate_1)
HepG2/C3A Non-Target Expressing cells (Replicate_3)
HepG2/C3A Non-Target Expressing cells (Replicate_2)
HepG2/C3A Non-Target Expressing cells (Replicate_1)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on